Melanoma Brain Metastases and Vemurafenib: Need for Further Investigation

submitted by: WentzMR
Dr. Roxana Dronca, a Medical Oncologist, Senior Associate Consultant, and Assistant Professor of Oncology at Mayo Clinic in Rochester, MN, discusses her article appearing in the October 2012 issue of Mayo Clinic Proceedings where she confirms the need for continued vigilance for brain metastases in patients with BRAF mutated metastatic melanoma, despite simultaneous successful response of extracranial metastases to BRAF-targeted therapy with vemurafenib. Available at:...

The Origin of Vertebrates - Part 2: Telling the Back from the Front or What the Chordates Invented (27:47)

submitted by: video_collector

In Part 2: Telling the back from the front or what the chordates invented, Marc Kirschner (Harvard Medical School) discusses why we look like invertebrate animals turned upside down, i.e. vertebrates have their central nervous system on their backs and invertebrates have it on their bellies.

Therapies for Multiple Sclerosis

submitted by: alex01

J. Kocsis, PhD. - The current approaches to the therapy of multiple sclerosis are reviewed by J. Kocsis (Yale University). His research emphasizes remyelination as an approach to the therapy of multiple sclerosis and spinal cord injury.

Drug Discovery for Alzheimer's Disease

submitted by: alex01

Gregory Rose from PharmExperts.com interviews J. Buccafusco (Medical College of Georgia, Augusta, GA) about his development of new anti-Altzheimer drugs, designed to act by multiple mechanisms to improve congnition. Desensitization of nicotinic receptors is one of the novel approaches proposed by Buccafusco. Three of his compounds are currently in advanced preclinical evaluation.

MacArthur Fellow 2008: Sally Temple, neuroscientist

submitted by: video_collector
Sally Temple is a neuroscientist tracing the natural interactions of differentiating neurons, bringing us closer to developing effective methods for treating central nervous system damage. MacArthur Fellowships offer the opportunity for Fellows to accelerate their current activities or take their work in new directions. The unusual level of independence afforded to Fellows underscores the spirit of freedom intrinsic to creative endeavors. The extraordinary creativity of MacArthur...

Robert Yolken (CNS Disease Session)

submitted by: hhv-6foundation

"Elevated levels of antibodies to HHV-6 in individuals with schizophrenia: Results from a hypothesis generating case-control study among military personnel"
6th International Conference on HHV-6 & 7 in Baltimore, Maryland, USA
Day 3 - June 22, 2008 - CNS Disease Session

Steven Jacobson (CNS Disease Session)

submitted by: hhv-6foundation

"The association of the human herpesvirus-6 (HHV-6) in diseases of the nervous system"
6th International Conference on HHV-6 & 7 in Baltimore, Maryland, USA
Day 3 - June 19-22, 2008 - CNS Disease Session